AS was of rheumatic cause, with commisural fusion and little calcification. The aortic annulus and sinuses of Valsalva diameters were 22 and 30 mm, respectively. Systolic pulmonary artery pressure was 60 mm Hg. Coronary angiography showed normal epicardial coronary arteries, the calculated logistic EuroSCORE was 21. She was declined for surgery on the basis of prior cardiac surgery and poor left ventricular function.
Conclusion
This report shows that TAVI could be safe, feasible and effective treatment in patients with rheumatic AS in selected no-option patients. Embolization of the valve may become an issue, and could be a drawback to this approach. 
Introduction
Prosthetic mitral valve thrombosis (PVT) is a serious complication of valve replacement which carries a high risk of mortality. However, the optimal treatment method for PVT remains controversial. Here, we report a case of PVT with an echoluscent-structured thrombus diagnosed on a mechanical mitral valve and the use of a low-dose tissue plasminogen activator (tPA).
Case Report
A 37-year old woman was admitted to our clinic with complaints of respiratory distress and fatigue. Her history included mitral valve replacement surgery a year ago due to rheumatic heart disease. The Case Reports Anadolu Kardiyol Derg 2014; 14: 296-302 patient, who had been using warfarin and receiving regular INR testing, had targeted INR values ten days ago. A week ago, she used oral prednisone for lower back pain which she had stopped taking two days ago. On physical examination, rales were heard bilaterally on the basal regions of the lungs. The haemoglobin and leukocyte count were normal.The erythrocyte sedimentation rate was 60 mm/hour, CRP was 40.8 mg/L (0-6 mg/L) and INR was 1.58. Transthoracic echocardiography (TTE) revealed a mobile non-obstructive mass attached to the mechanical mitral valve. The maximum and mean transmitral diastolic gradients were determined to be 24/10 mm Hg, mitral valve area was measured as 1.4 cm 2 , and it was assumed that the high gradient was related secondary to the high rate. Patient blood samples were obtained for microbial analysis, and antibiotic treatment directed at infective endocarditis (IE) was administered. Subsequently, transesophageal echocardiography (TEE) was performed. A 14x9 mm sized non-obstructive, echoluscent-structured, mobile mass was detected which was attached to the annulus posterior to the prosthetic mitral valve and mild physiological mitral insufficiency was observed ( Fig. 1 , Video 1. See correspondening video/movie images at www.anakarder.com). The medical council concluded that the mass on the prosthetic valve was compatible with a newly formed thrombus, and that thrombolytic therapy (TT) should be applied to the patient. The patient was administered an intravenous infusion of 25 mg tPA in 12 hours. The 24 hour control TEE revealed that the thrombus had disappeared, and that in its place only a residue was visualized (Fig. 2 , Video 2. See correspondening video/movie images at www.anakarder.com). No complications occurred and the patient was discharged after the antiaggregant therapy was re-regulated.
Discussion
PVT is a rare but serious complication of valve replacement. The most frequent cause of PVT is insufficient anticoagulation. Surgical technique, type of valve used, localization of the valve, and presence of a pannus and the hemodynamic situation of the patient are other important reported causes of thrombus formation on mechanical valves (1). Although PVT can present acutely as a fresh thrombus, it is most often a subacute or chronic phenomenon. Thrombi are typically formed of different clot layers, with varying degrees of organisation (2) . TEE is the gold standard in the confirmation of diagnosis (3). Since the margins of the thrombus were prominent and the internal structure was translucent on TEE, we concluded that the thrombus had newly formed.
Different recommendations for the surgical or TT of PVT are given in the guidelines. Since TT has a risk of embolism, the 2007 European valvular heart disease guideline primarily recommends surgical treatment. According to these guidelines, TT is recommended only in PVTs of the right side, and in left side PVTs that are inoperable (4). In the guideline prepared by Lengyel et al. (5) , in obstructive PVT, the rates of success, systemic embolism and mortality of TT treatment were reported to be 82%, 12% and 6% respectively, and if not contraindicated, it was recommended that TT be the first step in therapy. It has been reported in literature that TT should not be performed in the presence of left atrial thrombus due to the high risk of embolism (5) . Furthermore, a multicenter PRO-TEE study has reported that the risk of embolism was higher with TT in patients with a thrombus area of >0.8 cm 2 (6) .
There is no consensus on the proper dose and duration of TT in PVT. In the high-series study of Özkan et al. (7) (TROIA study), different TT protocols were compared in patients with PVT, and no difference was observed between the success rates of different agents (streptokinase, tPA). Moreover, the lowest complication rate was reported in the low-dose and slow infused (25 mg/6 hours) tPA group. In the study, repeated infusions of were required in the majority of patients given low-dose tPA. In our case, the very short duration of subtherapeutic warfarin use and dissolution of the thrombus after a single dose administration of tPA 25 mg supported our assumption that the thrombus was a very newly formed one.
Conclusion
This case was presented in order to highlight the effective and reliable treatment option of low-dose TT by slow infusion in patients with PVT with special thrombus morphology. Video 1. TEE on admission: Nonobstructive, echoluscent-structured mobile mass was detected which was attached to the annulus posterior to the prosthetic mitral valve Video 2. TEE after treatment: The thrombus had disappeared, and in its place only a residue was visualied Figure 1 . TEE on admission: Nonobstructive, echoluscent-structured mobile mass was detected which was attached to the annulus posterior to the prosthetic mitral valve Figure 2 . TEE after treatment: The thrombus had disappeared, and in its place only a residue was visualied
Introduction
The left atrial appendage (LAA) is a blind-ending, muscular extension of the left atrium and is of clinical importance in as much as the LAA is a place where a thrombus could be formed when the left atrial (LA) function decreases (1). However, it should routinely be analyzed as part of a transesophageal echocardiographic (TEE) examination (2) . The LAA cavity might very rarely have membranes. Indeed, only less than ten cases of a membrane involving the LAA have been described in the literature. The origin of membranes involving the LAA is not clear. The most likely explanation for the origin of these membranes would appear to be a congenital anatomic variation (3) .
We report a case of a non-obstructive membrane at the orifice of the LAA on TEE, mimicking a mobile thrombus attached to it.
Case Report
A 42-year-old woman, with no history of cardiovascular disease, presented with palpitations and dyspnea. A 12-lead electrocardiogram showed atrial flutter with an acceptable ventricular rate, and a twodimensional echocardiogram was normal except for a mildly dilated LA. A pre-cardioversion TEE examination illustrated a linear, membranelike structure traversing the orifice of the LAA (Fig. 1, Video 1 . See correspondening video/movie images at www.anakarder.com). Color Doppler did not demonstrate flow acceleration across this membrane (Fig. 2, Video 2 . See correspondening video/movie images at www. anakarder.com). Pulsed-wave Doppler confirmed low-flow velocities across the membrane, indicating no obstruction (Fig. 3 ) but a mobile linear particle (4 mm) mimicking a thrombus attached to the LAA. Accordingly, the mobile particle structure was considered thrombosis and anticoagulation therapy before cardioversion was recommended.
After six weeks with the patient on good anticoagulation, a second 2D and 3D-TEE examination yielded similar images and configurations (Fig. 4, Video 3, 4) . The moving particle attached to the LAA membrane was, therefore, deemed a structural variant, and electrical cardioversion was performed successfully. After electrical cardioversion, the patient recovered sinus rhythm and was discharged on standard therapy. 
